BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3671881)

  • 1. Theophylline disposition during acute and chronic hypoxia in the conscious dog.
    Saunier C; du Souich P; Hartemann D; Sautegeau A
    Res Commun Chem Pathol Pharmacol; 1987 Sep; 57(3):291-9. PubMed ID: 3671881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease.
    Knoppert DC; Spino M; Beck R; Thiessen JJ; MacLeod SM
    Clin Pharmacol Ther; 1988 Sep; 44(3):254-64. PubMed ID: 3046811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood oxygen tension-related change of theophylline clearance in experimental hypoxemia.
    Kishimoto I; Tanigawara Y; Okumura K; Hori R
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1237-42. PubMed ID: 2703972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fluconazole on theophylline disposition in humans.
    Konishi H; Morita K; Yamaji A
    Eur J Clin Pharmacol; 1994; 46(4):309-12. PubMed ID: 7957514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of interaction between theophylline and mexiletine.
    Ueno K; Miyai K; Kato M; Kawaguchi Y; Suzuki T
    DICP; 1991; 25(7-8):727-30. PubMed ID: 1949927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of terfenadine on theophylline pharmacokinetics and metabolism in normal subjects.
    Brion N; Naline E; Beaumont D; Pays M; Advenier C
    Br J Clin Pharmacol; 1989 Mar; 27(3):391-5. PubMed ID: 2497767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The theophylline-enoxacin interaction: I. Effect of enoxacin dose size on theophylline disposition.
    Rogge MC; Solomon WR; Sedman AJ; Welling PG; Toothaker RD; Wagner JG
    Clin Pharmacol Ther; 1988 Nov; 44(5):579-87. PubMed ID: 3180639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental changes in urinary elimination of theophylline and its metabolites in pediatric patients.
    Tateishi T; Asoh M; Yamaguchi A; Yoda T; Okano YJ; Koitabashi Y; Kobayashi S
    Pediatr Res; 1999 Jan; 45(1):66-70. PubMed ID: 9890610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal clearance of theophylline and its major metabolites: age and urine flow dependency in paediatric patients.
    Bonnacker I; Berdel D; Süverkrüp R; von Berg A
    Eur J Clin Pharmacol; 1989; 36(2):145-50. PubMed ID: 2721539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theophylline pharmacokinetics in normal elderly subjects.
    Shin SG; Juan D; Rammohan M
    Clin Pharmacol Ther; 1988 Nov; 44(5):522-30. PubMed ID: 3180633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m).
    Streit M; Göggelmann C; Dehnert C; Burhenne J; Riedel KD; Menold E; Mikus G; Bärtsch P; Haefeli WE
    Eur J Clin Pharmacol; 2005 Mar; 61(1):39-46. PubMed ID: 15692829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in man.
    Monks TJ; Lawrie CA; Caldwell J
    Biopharm Drug Dispos; 1981; 2(1):31-7. PubMed ID: 7236869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-drug interactions affecting fluoroquinolones.
    Wijnands GJ; Vree TB; Janssen TJ; Guelen PJ
    Am J Med; 1989 Dec; 87(6C):47S-51S. PubMed ID: 2603893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline disposition in patients with COLD with and without hypoxemia.
    du Souich P; Hoen B; Saunier C; Hartemann D; Sautegeau A; Cornette A; Delorme N; Polu JM; Sadoul P
    Chest; 1989 May; 95(5):1028-32. PubMed ID: 2495903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of enoxacin on renal and metabolic clearance of theophylline in rats.
    Nadai M; Hasegawa T; Kuzuya T; Muraoka I; Takagi K; Yoshizumi H
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1739-43. PubMed ID: 2285287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of theophylline metabolites in healthy adults.
    Rodopoulos N; Norman A
    Scand J Clin Lab Invest; 1997 May; 57(3):233-40. PubMed ID: 9238759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants.
    Sohn JA; Kim HS; Oh J; Cho JY; Yu KS; Lee J; Shin SH; Lee JA; Choi CW; Kim EK; Kim BI; Park EA
    Br J Clin Pharmacol; 2017 Jun; 83(6):1279-1286. PubMed ID: 27995649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acute and chronic moderate hypoxia on diltiazem kinetics and metabolism in the dog.
    du Souich P; Hartemann D; Saunier C
    Pharmacology; 1993 Dec; 47(6):378-85. PubMed ID: 8278460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of excretion characteristics of theophylline and its major metabolites.
    Jonkman JH; Tang D; Upton RA; Riegelman S
    Eur J Clin Pharmacol; 1981; 20(6):435-41. PubMed ID: 7286053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of methylxanthine-containing foods on theophylline metabolism and kinetics.
    Monks TJ; Caldwell J; Smith RL
    Clin Pharmacol Ther; 1979 Oct; 26(4):513-24. PubMed ID: 487699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.